NCT02833948
Comparison of a Rivaroxaban-based Strategy With an Antiplatelet-based Strategy Following Successful TAVR for the Prevention of Leaflet Thickening and Reduced Leaflet Motion as Evaluated by Four-dimensional, Volume-rendered Computed Tomography (4DCT)
Phase: Phase 3
Role: Collaborator
Start: May 31, 2016
Completion: Mar 6, 2019